ProtoKinetix

ProtoKinetix Net Tangible Assets

The Net Tangible Assets of ProtoKinetix (PKTX) as of Nov 19, 2026 is 297,940.00 USD. In the previous year, Net Tangible Assets was -127,710.00 USD — a change of -333.29% (higher).

Net Tangible Assets

297,940.00USD

YoY

-333.29%

Last updated:

Net Tangible Assets of ProtoKinetix is 2025 297,940.00 USD. Net Tangible Assets of ProtoKinetix was 2024 -127,710.00 USD. It decreases by -333.29% higher compared to the previous year.

The ProtoKinetix Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
58,165.00 USD
Jan 1, 2019
352,887.00 USD
Jan 1, 2020
149,521.00 USD
Jan 1, 2021
-9,734.00 USD
Jan 1, 2022
-14,960.00 USD
Jan 1, 2023
-23,239.00 USD
Jan 1, 2024
-127,710.00 USD
Jan 1, 2025
297,940.00 USD
The ProtoKinetix Net Tangible Assets history
YEARNet Tangible AssetsYoY
297,940.00USD-333.29%
-127,710.00USD+449.55%
-23,239.00USD+55.34%
-14,960.00USD+53.69%
-9,734.00USD-106.51%
149,521.00USD-57.63%
352,887.00USD+506.70%
58,165.00USD-73.63%
220,535.00USD-44.32%
396,099.00USD+18.57%
334,064.00USD-177.99%
-428,329.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProtoKinetix Stock analysis

What does ProtoKinetix do? ProtoKinetix Inc. is a Canadian biotechnology company focused on the development of glycoproteins for therapeutic applications. The company was founded in 2005 and is headquartered in Marietta, USA. ProtoKinetix specializes in the research and development of AAGP® (Anti-Aging Glycopeptide) as biopharmaceuticals. These proprietary glycoproteins have the ability to protect cells and can be used in various therapeutic applications for improving damage in physical injury, spinal cord injury, diabetes, transplantation, and retinal diseases. In addition to the medical field, ProtoKinetix is also developing its patented technology for use in bio-agriculture and animal healthcare. It has a subsidiary that holds the rights to use and distribute AAGP® and its patents. ProtoKinetix's business model involves licensing its glycoprotein technology for various applications, including biopharmaceuticals, bioprocessing industries, and cell protection management for regenerative medicine and stem cell preparations. The company has established partnerships with other biotech companies to integrate its AAGP® technology into their product pipelines. ProtoKinetix's flagship product is the AAGP® protein solution, which is used as a medication in regenerative medicine, organ transplantation, eye healing, and animal health. It is also interested in researching the application of AAGP® in crop farming to increase yields and improve soil quality. ProtoKinetix is poised to play a significant role in the development of glycoproteins as future medicines and therapeutic technologies in various industries. It not only has the potential to explore healing medical products but also aims to enhance agriculture and animal care. ProtoKinetix represents an excellent example of a biotechnology company focused on improving the healthcare and agricultural industries. ProtoKinetix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProtoKinetix stock

Net Tangible Assets of ProtoKinetix is 297,940.00 USD in 2025.

Net Tangible Assets of ProtoKinetix changed from -127,710.00 USD to 297,940.00 USD, representing a -333.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets ProtoKinetix since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's ProtoKinetix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ProtoKinetix

All Key Metrics — ProtoKinetix